Industry news

  • 15 April 2015

    Clinical studies in the registration of imported drugs may cancel

    market-access-solutions.ru

    The Federal Antimonopoly Service intends to initiate a maximum simplification of registration of foreign drugs in Russia. FAS head Igor Artemyev hopes to receive an official commission of the government on this issue. The most likely option to simplify - the recognition of clinical studies conducted abroad with the approval of the drug FDA, EMEA or regulators in other countries. 

  • 14 April 2015

    USC pilot program illustrates importance of clinical pharmacists

    Drug Store News

    A University of Southern California pilot currently underway at several clinics belonging to nonprofit clinic AltaMed is illustrating the important role that pharmacists can play in improving patient outcomes and easing the burden of the nation’s shortage of primary care physicians, according to a Los Angeles Times article.

  • 14 April 2015

    Krasnoyarsk nanodiamonds for new displays and medical diagnostics

    Marchmont Innovation News

    Siberian scientists in Krasnoyarsk have developed a new composite material based on carbon nanotubes and nanodiamonds, Nanonewsnet.ru  reported , citing a source at the Krasnoyarsk-based Institute of Biophysics. 

  • 14 April 2015

    India plans medical device industrial parks as part of 'Make in India' campaign

    Varun Saxena / FierceMedicalDevices

    India is planning to open its first medical device industrial park in Gujarat, the state whose strong economic performance propelled Narendra Modi, its former chief minister, to the prime ministership. Discussions are underway for a second park in the south Indian state of Tamil Nadu.

  • 14 April 2015

    Patient focus a challenge in treating chronic diseases like diabetes

    Mari Serebrov / BioWorld

    As health care across the globe shifts to a more patient-focused model, one of the challenges is getting patients to be more accountable for their own health.

  • 13 April 2015

    Data registry finds younger orthopedics patients are no healthier than older ones

    Varun Saxena / FierceMedicalDevices

    The Framingham Heart Study has revolutionized cardiology over the decades, leading to insights like the dangers of smoking in the 1960s, elevated blood pressure in the 1970s and more recently, genomic risk factors. Another Massachusetts study is underway, with the intention of becoming the equivalent study in the orthopedics arena, according to Dr. David Ayers, chair of the orthopedics department at the University of Massachusetts Medical School in Worcester.

  • 13 April 2015

    VCs start 2015 off with a bang, IPOs more like a whimper

    Brian Orelli / BioWorld

    Neither snow in Boston nor a drought in California could stop venture capitalists from handing out cash in the first quarter to start-ups and established private companies alike. Funding of private U.S. drug companies tracked by BioWorld increased to $1.94 billion in the first quarter of 2015, more than double the $814 million VCs handed out in the year-ago quarter.

  • 13 April 2015

    Direct-to-consumer ads pump sales for some indications, flounder for others

    Jennifer Boggs / BioWorld

    Getting a drug through today's rigorous and costly development and regulatory processes – a 2014 Tufts study estimated more than a decade and $2.6 billion in expenses – might seem like the endgame. But the next step, getting that drug into the hands of doctors and patients, is just as crucial, and that's where a successful direct-to-consumer (DTC) marketing campaign could make the difference between a market leader and an also-ran.

  • 13 April 2015

    Woodford boosts biotech fund max to $1.2B as investors crowd in

    John Carroll / FierceBiotech

    When U.K. investment guru Neil Woodford outlined his initial plans for a new, publicly traded tech fund that would seek out up-and-coming biotechs for its portfolio, he pegged the fund as a $300 million player with an option to jump to $750 million if it proved popular.

  • 10 April 2015

    Asian device market set to leap to $15B in 2017

    EJ Lane / FeircePharmaAsia

    A survey of the top 100 makers of medical devices in Asia indicates the industry will reach the $15 billion mark in 2017, a huge leap from a market of just $2 billion in 2012. In addition to the top 100, Research and Markets also focused individually on the device markets in India, Japan and South Korea, all three major ones. Japan, in fact, has the second largest in the world, behind only the United States.

All Portfolio

MEDIA CENTER